| mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
-0.27 |
3e-08 |
| mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.26 |
2e-07 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-07 |
| mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-07 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-06 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-06 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-06 |